Mission Therapeutics Is A Clinical Stagebiotechnology Company Based In Cambridgeukthecompany Specializes In Discovering And Developing Small Moleculetherapeutics That Target Deubiquitylating Enzymesdubs Its Mission Is To Address Diseases With Significant Unmet Medical Needsincluding Neurodegenerativedisorders Likeparkinsonaes Diseaseas Well As Heart And Kidney Diseasesfibrosisand Raremitochondrial Conditionsmission Has Successfully Raised A 117 Million In Venturecapitalestablishing Itself As A Leader In Dub Targeted Drug Development Thecompany S Proprietary Platform Focuses On Selectively Inhibiting Diseaseassociated Dubs To Restorecellular Healthits Lead Candidatemtx 25Targets Usp 0 And Is In Development For Parkinsonaes Diseaseand Other Neurodegenerativedisordersanother Candidatemtx652Is Advancing Toward Clinical Trials For Kidney And Heart Diseasesmission Also Has Preclinical Programs For Fibrosis And Rarediseasesdeveloped Both In Houseand Through Partnerships With Institutions Liketheuniversity Of Cambridgeand Cancer Research Uk Laboratories
